Nisa Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.3M | Sell |
19,771
-1,191
| -6% | -$912K | 0.06% | 200 |
|
|
2025
Q4 | $16.2M | Buy |
20,962
+950
| +5% | +$645K | 0.05% | 199 |
|
|
2025
Q3 | $11.3M | Sell |
20,012
-739
| -4% | -$418K | 0.04% | 250 |
|
|
2025
Q2 | $10.9M | Sell |
20,751
-26,595
| -56% | -$14.8M | 0.05% | 248 |
|
|
2025
Q1 | $30M | Sell |
47,346
-1,510
| -3% | -$1.04M | 0.15% | 120 |
|
|
2024
Q4 | $34.8M | Buy |
48,856
+19,114
| +64% | +$16M | 0.14% | 117 |
|
|
2024
Q3 | $31.3M | Buy |
29,742
+7,506
| +34% | +$8.35M | 0.19% | 114 |
|
|
2024
Q2 | $23.4M | Buy |
22,236
+788
| +4% | +$764K | 0.15% | 146 |
|
|
2024
Q1 | $20.6M | Sell |
21,448
-795
| -4% | -$756K | 0.13% | 164 |
|
|
2023
Q4 | $19.5M | Sell |
22,243
-390
| -2% | -$321K | 0.14% | 159 |
|
|
2023
Q3 | $18.6M | Sell |
22,633
-1,082
| -5% | -$850K | 0.14% | 162 |
|
|
2023
Q2 | $17M | Sell |
23,715
-597
| -2% | -$460K | 0.13% | 176 |
|
|
2023
Q1 | $20M | Buy |
24,312
+3,913
| +19% | +$2.95M | 0.16% | 153 |
|
|
2022
Q4 | $14.7M | Sell |
20,399
-590
| -3% | -$435K | 0.12% | 206 |
|
|
2022
Q3 | $14.5M | Sell |
20,989
-2,032
| -9% | -$1.28M | 0.12% | 178 |
|
|
2022
Q2 | $13.6M | Buy |
23,021
+2,494
| +12% | +$1.62M | 0.12% | 190 |
|
|
2022
Q1 | $14.3M | Hold |
20,527
| – | – | 0.1% | 200 |
|
|
2021
Q4 | $12.5M | Sell |
20,527
-2,315
| -10% | -$1.42M | 0.09% | 224 |
|
|
2021
Q3 | $13.8K | Buy |
22,842
+400
| +2% | +$248K | 0.08% | 216 |
|
|
2021
Q2 | $12.5K | Buy |
22,442
+2,248
| +11% | +$1.14M | 0.08% | 234 |
|
|
2021
Q1 | $9.55K | Sell |
20,194
-1,135
| -5% | -$553K | 0.06% | 278 |
|
|
2020
Q4 | $10.3M | Sell |
21,329
-1,840
| -8% | -$993K | 0.07% | 274 |
|
|
2020
Q3 | $13M | Sell |
23,169
-1,697
| -7% | -$1.03M | 0.1% | 203 |
|
|
2020
Q2 | $15.5M | Sell |
24,866
-5,191
| -17% | -$2.95M | 0.14% | 154 |
|
|
2020
Q1 | $14.7M | Buy |
30,057
+3,060
| +11% | +$1.26M | 0.16% | 139 |
|
|
2019
Q4 | $10.1M | Buy |
26,997
+5,597
| +26% | +$1.88M | 0.09% | 223 |
|
|
2019
Q3 | $5.94M | Sell |
21,400
-576
| -3% | -$170K | 0.05% | 338 |
|
|
2019
Q2 | $6.88M | Buy |
21,976
+1,995
| +10% | +$664K | 0.07% | 291 |
|
|
2019
Q1 | $8.21M | Sell |
19,981
-1,400
| -7% | -$577K | 0.08% | 240 |
|
|
2018
Q4 | $7.99M | Sell |
21,381
-261
| -1% | -$95.5K | 0.09% | 221 |
|
|
2018
Q3 | $8.74M | Buy |
21,642
+3,098
| +17% | +$1.18M | 0.08% | 240 |
|
|
2018
Q2 | $6.4M | Sell |
18,544
-8,577
| -32% | -$2.68M | 0.07% | 290 |
|
|
2018
Q1 | $9.27M | Buy |
27,121
+5,286
| +24% | +$1.84M | 0.1% | 212 |
|
|
2017
Q4 | $8.21M | Sell |
21,835
-1,641
| -7% | -$665K | 0.08% | 237 |
|
|
2017
Q3 | $10.5M | Buy |
23,476
+2,371
| +11% | +$1.13M | 0.12% | 195 |
|
|
2017
Q2 | $10.2M | Sell |
21,105
-100
| -0.5% | -$43.8K | 0.12% | 186 |
|
|
2017
Q1 | $8.22M | Buy |
21,205
+7,159
| +51% | +$2.65M | 0.1% | 226 |
|
|
2016
Q4 | $5.16M | Sell |
14,046
-1,394
| -9% | -$530K | 0.06% | 306 |
|
|
2016
Q3 | $6.21M | Buy |
15,440
+1,500
| +11% | +$602K | 0.08% | 260 |
|
|
2016
Q2 | $4.87M | Sell |
13,940
-900
| -6% | -$347K | 0.07% | 319 |
|
|
2016
Q1 | $5.35M | Buy |
14,840
+620
| +4% | +$255K | 0.08% | 276 |
|
|
2015
Q4 | $7.72M | Buy |
14,220
+400
| +3% | +$217K | 0.11% | 193 |
|
|
2015
Q3 | $6.55M | Buy |
13,820
+2,820
| +26% | +$1.51M | 0.1% | 202 |
|
|
2015
Q2 | $5.61M | Sell |
11,000
-200
| -2% | -$97.6K | 0.08% | 260 |
|
|
2015
Q1 | $5.06M | Buy |
11,200
+200
| +2% | +$84.8K | 0.07% | 290 |
|
|
2014
Q4 | $4.51M | Sell |
11,000
-200
| -2% | -$78.7K | 0.06% | 317 |
|
|
2014
Q3 | $4.04M | Buy |
11,200
+700
| +7% | +$235K | 0.06% | 323 |
|
|
2014
Q2 | $2.97M | Sell |
10,500
-400
| -4% | -$119K | 0.04% | 433 |
|
|
2014
Q1 | $3.27M | Buy |
10,900
+900
| +9% | +$277K | 0.05% | 387 |
|
|
2013
Q4 | $2.75M | Buy |
10,000
+300
| +3% | +$86.3K | 0.04% | 439 |
|
|
2013
Q3 | $3.04M | Sell |
9,700
-3,900
| -29% | -$1.03M | 0.05% | 396 |
|
|
2013
Q2 | $3.06M | Buy |
+13,600
| New | +$3.17M | 0.05% | 374 |
|
Other funds holding REGN
VCM
N
Nisa Investment Advisors's REGN Position: Q1 2026 in Review
Nisa Investment Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 5.7% in Q1 2026, selling an estimated $912K and leaving 19,771 shares worth $15.3M. The position accounts for 0.06% of the portfolio, ranked #200.
Nisa Investment Advisors first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.8M in Q4 2024. 1,396 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Nisa Investment Advisors held 19,771 shares of Regeneron Pharmaceuticals worth $15.3M as of Q1 2026.
- Nisa Investment Advisors sold 1,191 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $912K.
- Regeneron Pharmaceuticals made up 0.06% of Nisa Investment Advisors's portfolio in Q1 2026, its #200 holding.
- Nisa Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Nisa Investment Advisors's Regeneron Pharmaceuticals position peaked at $34.8M in Q4 2024.
- 1,396 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.